Technologies Room Programme

In the Biotech Investment Room

8.15 – 9.15  Registration

9.15 – 9.20  Welcome From the Conference Founder
Mattias Johansson, Director, Ezenze Ltd

9.20 – 9.40  Welcome Address
Sarah Haywood, CEO, MedCity

In the Technologies Room

9:45 – 10.30  Company Presentations
Session Chair: Madeleine Armstrong, Reporter, EP Vantage

EnXray         Predicare AB         Active Needle Technology         Glide Technologies         ScioVR         Transplant Biomedicals

10:30 Coffee (Exhibitor area, ground floor)

10:50-11:20 Company Presentations

ScioVR         Transplant Biomedicals

11.20 – 11.40  Enablers and Technologies from the Pharma perspective
Dr Birgit Reitmaier MBA, Head of Technologies & Biomarkers Merck KGaA

In the Biotech Investment Room

11.40 – 12.00  New therapies: Precision Medicine & Neurodegenerative Disease
Baroness Prof Susan Greenfield, CEO, NeuroBio Ltd.

12.00 – 13.15  LUNCH
In the Exhibition area (ground floor). Sponsored by Precision Oncology

In the Technologies Room

13.15 – 14.00  Advancing life sciences technologies that will significantly impact the healthcare sector
Chair:  Dr Nima Jokilaakso, Project Manager Digital Health Swecare Foundation
Panelists: Dr Rudy Dekeyser, Partner LSP; Eyal Rabinovich, Investment Associate, Octopus Ventures; Dr Birgit Reitmaier MBA, Head of Technologies & Biomarkers Merck KGaA; Dr Richard Wyse, Director of Research and Development at The Cure Parkinson’s Trust

14.00 – 15.05  Company Presentations
Session Chair: Tina Tan, Editor-in-Chief, Medtech Insight

Aglaris         Brain Stimulation         Hiloprobe         Tridentify       Calcivis      Unguis

15:05 Coffee (Exhibitor area, ground floor)

15.15 – 15.45  Swedish Industry strength through collaboration
Anders Lönnberg,  National Life Sciences Coordinator, Government of Sweden

15.45 – 16.15  Delivering Clinical Research to make Patients, and the NHS, better
Divya Chadha Manek, Head of Business Development, NIHR Clinical Research Network

16.15 – 16.45  Investment Status In The Innovative Technologies
Edward Kliphuis, Investment Director, Merck Ventures

In the Biotech Investment Room

16.45 – 17.00  Latest News on European Funding
Hakan Goker, Investment Director, Merck Ventures

17.00 – 17.15  Conclusions and Q & A

17.15 – 18.30 Afternoon Drinks Reception
Hosted by Mattias Johansson, Director, Ezenze Ltd